Clinical trials in the elderly: Ethical and methodological considerations;Essais therapeutiques chez le sujet age: Particularites ethiques et methodologiques

Revue de Medecine Interne

Volumn 21, Issue 7, 2000, Pages 614-622

  Berdeu, D ^a   Herve C ^a   Fourcade, J ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hopital Gaston Doumergue   (France)

Author keywords

Ageing; Clinical trial; Elderly; Ethics; Methodology

Indexed keywords

AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHICS; GERONTOLOGICAL RESEARCH; HUMAN; INFORMED CONSENT; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; BIOETHICS; MEDICAL ETHICS; REPRODUCIBILITY; RESEARCH; REVIEW;

AGED; BIOETHICS; CLINICAL TRIALS; ETHICS, MEDICAL; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH;

EID: 0034235107     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)80007-7     Document Type: Article

References (74)

1. 1 Clarfield AM, Friedman R. Survey of the age structure of 'age relevant' articles in four general medical journals. J Am Geriatr Soc 1985; 33:773-8.
2. 2 Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. Five year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality. JAMA 1979; 242: 2562-71.
3. 3 Report by the Management Committee: the Australian therapeutic trial in mild hypertension. Lancet 1980; i: 1261.
4. 4 Wassertheil-Smoller S, Blaufox MD, Oberman A, Davis BR, Swencionis C, O'Connell Knerr M, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med 1991; 114: 613-20.
5. 5 Applegate WB. Hypertension in elderly patients. Ann Intern Med 1989; 110: 901-15.
6. 6 Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417-22.
7. 7 Goldberg RJ, Gore JM, Gurwitz JH. The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J 1989; 117: 543-9.
8. 8 Ries LG, Hankey BF, Miller BA. Cancer Statistics Review 1973-1988. National Institutes of Health publication No 91-2789. Washington DC: National Institutes of Health; 1992.
9. 9 Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer 1994; 74: 2208-14.
10. 10 Kotwall CA, Mahoney LJ, Myers RE, Decoste L. Reasons for non-entry in randomized clinical trials for breast cancer: a single institutional study. J Surg Oncol 1992; 50: 125-9.
11. 11 Rothblum ED, Sholomskas AJ, Berry C, Prusoff BA. Issues in clinical trials with the depressed elderly. J Am Geriatr Soc 1982; 30: 694-9.
12. 12 Miller ST, Applegate WB, Perry C. Clinical trials in elderly persons. J Am Geriatr Soc 1985; 33: 91-2.
13. 13 Benson III AB, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists'reluctance to accrue patients onto clinical trials: an Illinois Cancer Center Study. J Clin Oncol 1991; 9: 2067-75.
14. 14 Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991; 114: 956-66.
15. 15 Wolf R. General medical and ethical problems of drug treatment in the elderly. Thérapie 1996; 51: 424-8.
16. 16 Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, et al. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992; 47: 137-44.
17. 17 Hurwitz N. Predisposing factors in adverse reactions to drugs. Br Med J 1969; 1: 536-9.
18. 18 Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: A multicenter investigation. Age Ageing 1980; 9: 73-9.
19. 19 Greenblatt DJ, Sellers EM, Shader RI. Drug disposition in old age. N Engl J Med 1982; 306: 1081-8.
20. 20 Vestal RE. Aging and pharmacology. Cancer 1997; 80: 1302-10.
21. 21 Simon R. Patient heterogeneity in clinical trials. Cancer Treat Rep 1980; 64: 405-10.
22. 22 Rowe JW, Kahn RL. Human aging: Usual and successful. Science 1987; 237: 143-9.
23. 23 Gold S, Clarfield AM, Davis MB. Clinical trials and the elderly [letter]. Ann Intern Med 1991; 115: 497.
24. 24 Wassertheil-Smoller S. Clinical trials and the elderly [letter]. Ann Intern Med 1991; 115: 497.
25. 25 White LR, Cartwright WS, Cornoni-Huntley J, Brock DB. Geriatric epidemiology. Annu Rev Gerontol Geriatr 1986; 6: 215-311.
26. 26 Cameron HJ, Williams BO. Clinical trials in the elderly. Should we do more? Drugs Aging 1996; 9: 307-10.
27. 27 Begg CB, Carbone PP. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 1983; 52: 1986-92.
28. 28 Giovanazzi-Bannon S, Rademaker A, Lai G, Benson III AB. Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study. J Clin Oncol 1994; 12: 2447-52.
29. 29 Davidson RA, Caranasos GJ. Should the elderly hypertensive be treated? Evidence from clinical trials. Arch Intern Med 1987; 147: 1933-7.
30. 30 Food and Drug Administration. Guideline for the study of drugs likely to be used in the elderly (DHHS Publication). Rockville (MD): Food and Drug Administration. Center for Drug Evaluation and Research Office of Drug Evaluation (HFD-100); 1989.
31. 31 Allain H, Le Coz F, Bureau M. Le volontaire sain âgé: une nécessité. Thérapie 1993; 48: 239-42.
32. 32 Kirkpatrick MA. Factors that motivate healthy adults to participate in phase 1 drug trials. Drug Inf J 1991; 25: 109-13.
33. 33 Schron EB, Wassertheil-Smoller S, Pressel S. Clinical trial participant satisfaction: survey of SHEP enrolles. SHEP Coopérative Research Group. Systolic Hypertension in the Elderly Program. J Am Geriatr Soc 1997; 45: 934-8.
34. 34 Turner P. Clinical trials in elderly subjects. Postgrad Med J 1989; 65: 218-20.
35. 35 Bernstein J, Nelson K. Médical expérimentation in the elderly. J Am Geriatr Soc 1975; 23: 327-9.
36. 36 Baker MT, Taub HA. Readability of informed consent forms for research in a Vétérans Administration Médical Center. JAMA 1983; 250: 2646-8.
37. 37 Morrow GR. How readable are subject consent forms. JAMA 1980; 244: 56-68.
38. 38 Simel DL, Feussner JR. A randomized controlled trial comparing quantitative informed consent formats. J Clin Epidemiol 1991; 44: 771-7.
39. 39 Isambert F. Le consentement: « le point de vue d'une éthique rationnelle ». Méd Hygiène 1986; 44: 2021-3.
40. 40 Laforet E. The fiction of informed consent. JAMA 1976; 235: 1579-85.
41. 41 Schultz AL, Pardee GP, Ensinck JW. Are research subjects really informed? West J Med 1975; 123: 76-80.
42. 42 Garnham JC. Some observations on informed consent in non-therapeutic research. J Med Ethics 1975; 1: 138-45.
43. 43 Taub HA. Informed consent, memory and age. Gerontologist 1980; 20: 686-90.
44. 44 Taub HA, Kline GE, Baker MT. The elderly patient and informed consent: Effects of vocabulary level and corrected feedback. Exp Aging Res 1981; 7: 137-46.
45. 45 Stanley B, Guido J, Stanley M, Shortell D. The elderly patient and informed consent: Empirical findings. JAMA 1984; 252: 1302-6.
46. 46 Applegate WB, Curb JD. Designing and executing randomized clinical trials involving elderly persons. J Am Geriatr Soc 1990; 38: 943-50.
47. 47 Warren TW, Sobal J, Tenney JH, Hoopes JM, Damron D, Levenson S, et al. Informed consent by proxy: an issue in research for elderly patients. N Engl J Med 1986; 315: 1124-7.
48. 48 Melnick VL, Dubler NN. Clinical research in senile dementia of the Alzheimer type: suggested guidelines addressing the ethical and légal issues. J Am Geriatr Soc 1984; 32: 531-41.
49. 49 Appelbaum PS, Grisso T. Assessing patient's capacities to consent to treatment. N Engl J Med 1988; 319: 1635-8.
50. 50 Grisso T. Evaluating competencies: forensic assessments and instruments. In: Sales BD, ed. Perspectives in law and psychology, 7. New York: Plenum Press; 1986.
51. 51 Kaplan KH. Assessing judgments. Gen Hosp Psychol 1988; 9: 202-8.
52. 52 Barbour GL, Blumenkrantz MJ. Videotape aids informed consent decision. JAMA 1978; 240: 2741-2.
53. 53 Miller R, Willner HS. The two-part consent form. A suggestion for promoting free and informed consent. N Engl J Med 1974; 290: 964-6.
54. 54 Kitler ME. Clinicat trials in the elderly. Pivotal points. Clin Geriatr Med 1990; 6: 235-55.
55. 55 Bell JA, May FE, Steward RB. Clinical research in the elderly: Ethical and methodological considerations. Drug Intell Clin Pharm 1987; 21: 1002-7.
56. 56 Gershon S. The conduct of clinical trials in the impaired elderly. Psychopharmacol Bull 1981; 17: 108-16.
57. 57 Kitler ME. Clinical trials and clinical practice in the elderly. A focus on hypertension. Drugs Aging 1992; 2: 86-94.
58. 58 Silagy CA, McNeil JJ, Parish S, McCloud PI, McGrath BP. Components of blood pressure variability in the elderly and effects on sample size calculations for clinical trials. Am J Hypertens 1992; 5: 449-58.
59. 59 Cutler NR, Sramek JJ. Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study. Eur J Clin Pharmacol 1995; 48: 421-8.
60. 60 Forette F. Panisset M, Boller F. Clinical trials in cognitive impairment in the elderly. Aging (Milano) 1992; 4: 239-50.
61. 61 Boult C, Boult L, Morishita L, Pirie P. Soliciting defined populations to recruit samples of high-risk older adults. J Gerontol A Biol Sci Med Sci 1998; 53: 379-84.
62. 62 Smith WM, Vogt TM. Ireland CC. Black D. Resources in geriatric drug research. Drug Inf J 1985; 19: 421-7.
63. 63 Kitler ME. The elderly in clinical trials. Drug Inf J 1989; 23: 123-37.
64. 64 Vestal RE. Methodological considerations for geriatric drug testing (phase 1 and 2 trials). Drug Inf J 1985; 19: 435-45.
65. 65 Volz HP, Möller HJ. Antidepressant drug therapy in the elderly: a critical review of the controlled clinical trials conducted since 1980. Pharmacopsychiatry 1994; 27: 93-100.
66. 66 Kaye JM, Lawton P, Kaye D. Attitudes of elderly people about clinical research in aging. Gerontologist 1990; 30: 100-6.
67. 67 Cheson BD, Nelson A. Clinical trials referral resource. Clinical trials in elderly patients. Oncology (Huntingt) 1997; 11: 838-42.
68. 68 Bowes SG, Dobbs SM. Dobbs RJ, Weller C. Outcome criteria in clinical trials with elderly subjects. Age Ageing 1990; 19: 353-5.
69. 69 Kutner NG, Ory MG, Baker DI, Schechtman KB. Hornbrock MC, Mulrow CD. Measuring the quality of life of the elderly in health promotion intervention clinical trials. Public Health Rep 1992; 107: 530-9.
70. 70 Curb JD. The trials and tribulations of clinical trials in the elderly. J Am Geriatr Soc 1994; 42: 682-3.
71. 71 Peto R, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Introduction and design. Br J Cancer 1976; 34: 585-612.
72. 72 Patriarca PA. A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility. JAMA 1994; 272: 1700-1.
73. 73 Meier P. Statistical analysis of clinical trials. In: Shapiro SH, Louis TA, eds. Clinical trials. New York: Marcel Dekker; 1983. p 155-89.
74. 74 Temple RT. The clinical investigation of drugs for use by the elderly: Food and drug guidelines. Clin Pharmacol Ther 1987; 42: 681-5.